Walleye Capital
ACET icon

Walleye Capital’s Adicet Bio ACET Stock Holding History

Walleye Capital’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-625
Closed -$24.3K – 4800
2023
Q2 		$24.3K Buy
+625
New +$55.2K ﹤0.01% 3774
2022
Q1 		– Sell
-12,966
Closed -$3.63M – 2252
2021
Q4 		$3.63M Buy
+12,966
New +$2.23M 0.11% 194
2020
Q3 		– Sell
-161
Closed -$39K – 810
2020
Q2 		$39K Buy
+161
New +$31.6K 0.01% 556

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Walleye Capital's ACET Position: Q3 2023 in Review

Walleye Capital sold out of Adicet Bio (ACET) in Q3 2023, closing a stake of 625 shares — an estimated $24.3K sold.

Walleye Capital first reported a position in ACET in Q2 2020 and held it in 3 quarters. The position peaked at $3.63M in Q4 2021. 83 funds tracked by Wall St. Rank hold ACET as of Q3 2023.

  • Walleye Capital reported no remaining Adicet Bio position as of Q3 2023 after selling out during the quarter.
  • Walleye Capital sold 625 Adicet Bio shares in Q3 2023, an estimated $24.3K.
  • Walleye Capital first reported a position in Adicet Bio in Q2 2020 and held it in 3 quarters.
  • Walleye Capital's Adicet Bio position peaked at $3.63M in Q4 2021.
  • 83 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2023.

Based on Walleye Capital's 13F filing for Q3 2023, filed 14 Nov 2023.